Nanostics Launches Study to Identify Potent Disease Predictors for Early Bladder Cancer Detection
Nanostics launched a prospective clinical study designed to validate a novel and minimally invasive bladder cancer diagnostic test.
Read More
Search Results for: bladder cancer
Cell-Free DNA Methylation Predicts Chemo Benefit in Bladder Cancer
Methylation patterns in cfDNA from blood samples can help predict which patients with a type of bladder cancer may benefit from chemotherapy.
Read More
Urine Test for Bladder Cancer Could Cut Need for Cystoscopies
Researchers have developed a new urine test for bladder cancer, which could significantly cut the need for invasive cystoscopies.
Read More
Nonagen’s Bladder Cancer Test Granted FDA Breakthrough Device Designation
Nonagen’s non-invasive bladder cancer test has been granted U.S. Food and Drug Administration (FDA) Breakthrough Device Designation.
Read More
Urine DNA Test Detects Bladder Cancer Data Shows
Promis Diagnostics recently presented data for CystoChek, a proprietary urine-based DNA methylation test of PENK for bladder cancer detection in hematuria.
Read More